213 related articles for article (PubMed ID: 15773539)
1. An update on the safety and efficacy of topical retinoids.
Phillips TJ
Cutis; 2005 Feb; 75(2 Suppl):14-22, 24; discussion 22-3. PubMed ID: 15773539
[TBL] [Abstract][Full Text] [Related]
2. Introduction. Contemporary perspectives on topical retinoids.
Leyden JJ
Cutis; 2005 Feb; 75(2 Suppl):4. PubMed ID: 15773536
[No Abstract] [Full Text] [Related]
3. A review of clinical experience and recommendations for improving patient care.
Weiss J
Cutis; 2005 Feb; 75(2 Suppl):32-8; discussion 39. PubMed ID: 15773541
[TBL] [Abstract][Full Text] [Related]
4. Topical retinoids in acne--an evidence-based overview.
Thielitz A; Abdel-Naser MB; Fluhr JW; Zouboulis CC; Gollnick H
J Dtsch Dermatol Ges; 2008 Dec; 6(12):1023-31. PubMed ID: 18479477
[TBL] [Abstract][Full Text] [Related]
5. Topical retinoids in acne vulgaris: update on efficacy and safety.
Thielitz A; Gollnick H
Am J Clin Dermatol; 2008; 9(6):369-81. PubMed ID: 18973403
[TBL] [Abstract][Full Text] [Related]
6. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of topical tazarotene in the treatment of mild to moderate acne.
Leyden JJ
Cutis; 2004 Oct; 74(4 Suppl):9-15. PubMed ID: 15543714
[TBL] [Abstract][Full Text] [Related]
8. Is switching retinoids a sound strategy for the treatment of acne vulgaris?
Gold LS; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s11-7. PubMed ID: 18575221
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the long-term safety of topical retinoids.
Bhawan J
Cutis; 2005 Feb; 75(2 Suppl):25-31. PubMed ID: 15773540
[TBL] [Abstract][Full Text] [Related]
10. Topical tazarotene therapy for psoriasis, acne vulgaris, and photoaging.
Guenther LC
Skin Therapy Lett; 2002 Mar; 7(3):1-4. PubMed ID: 12007011
[TBL] [Abstract][Full Text] [Related]
11. Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment.
Leyden JJ; Shalita A; Thiboutot D; Washenik K; Webster G
Clin Ther; 2005 Feb; 27(2):216-24. PubMed ID: 15811485
[TBL] [Abstract][Full Text] [Related]
12. Topical tazarotene: The BEST (balancing efficacy, speed, and tolerability) in acne trial.
Shalita A
Cutis; 2004 Oct; 74(4 Suppl):4-8. PubMed ID: 15543713
[TBL] [Abstract][Full Text] [Related]
13. Tazarotene: therapeutic strategies in the treatment of psoriasis, acne and photoaging.
Roeder A; Schaller M; Schäfer-Korting M; Korting HC
Skin Pharmacol Physiol; 2004; 17(3):111-8. PubMed ID: 15087589
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.
Thiboutot D; Arsonnaud S; Soto P
J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s3-10. PubMed ID: 18575220
[TBL] [Abstract][Full Text] [Related]
15. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
[TBL] [Abstract][Full Text] [Related]
16. [Topical retinoids in acne--an evidence-based overview].
Thielitz A; Abdel-Naser MB; Fluhr JW; Zouboulis CC; Gollnick H
J Dtsch Dermatol Ges; 2010 Mar; 8 Suppl 1():S15-23. PubMed ID: 20482688
[TBL] [Abstract][Full Text] [Related]
17. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
Tanghetti E; Dhawan S; Torok H; Kircik L
Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
[TBL] [Abstract][Full Text] [Related]
18. Optimizing treatment with topical tazarotene.
Guenther LC
Am J Clin Dermatol; 2003; 4(3):197-202. PubMed ID: 12627995
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial.
Webster GF; Berson D; Stein LF; Fivenson DP; Tanghetti EA; Ling M
Cutis; 2001 Jun; 67(6 Suppl):4-9. PubMed ID: 11499329
[TBL] [Abstract][Full Text] [Related]
20. Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.
Tanghetti E; Dhawan S; Green L; Ling M; Downie J; Germain MA; Kasteler JS; Kircik L; Oefelein MG; Draelos Z
J Drugs Dermatol; 2011 Jul; 10(7):783-92. PubMed ID: 21720661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
